What are the recommended treatment doses and dosing frequencies for catatonia, including lorazepam (benzodiazepine) and adjunctive agents such as amantadine and memantine?

Catatonia Treatment: Dose and Frequency

For acute catatonia, start lorazepam 1-2 mg IV/IM/PO every 4-8 hours, titrating up to 8-24 mg daily in divided doses based on response, with most patients responding within 24-48 hours.

First-Line Treatment: Lorazepam

Lorazepam is the established first-line pharmacological treatment for catatonia. The evidence consistently supports its use across multiple recent studies and clinical contexts 1, 2, 3, 4, 5.

Initial Dosing Strategy

• Start with 1-2 mg via IV, IM, or PO routes 6, 7, 1
• Administer every 4-8 hours as needed initially 6, 7
• For the lorazepam challenge test (diagnostic and therapeutic), 2 mg appears optimal rather than higher doses, as it demonstrates significant response to most catatonic signs 2

Dose Titration

• Most patients respond to 6-12 mg daily in divided doses 8
• Maximum doses of 8-24 mg daily may be required for severe or refractory cases 9, 1
• One case series documented successful treatment with doses up to 18 mg/day for chronic maintenance 9
• Titrate based on clinical response, typically increasing every few hours to days

Route Considerations

• Oral lorazepam (including sublingual use) is effective when patients can swallow 6, 7
• IV or IM routes are preferred for severe catatonia with inability to take oral medications 6, 7
• Response typically occurs within 24 hours, often within minutes to hours of administration 1, 2

Alternative Benzodiazepines

Midazolam

When IV lorazepam is unavailable, midazolam can serve as an alternative 3:

• 2.5-5 mg subcutaneously or IV every 2-4 hours as needed 6, 7
• Doses ranging from 4-32 mg IV daily or up to 48 mg oral daily have been tolerated 3
• May be used as adjunctive therapy, though appears most effective when combined with ECT 3
• For continuous infusion: start with 10 mg over 24 hours subcutaneously if needed frequently 6

Diazepam

For lorazepam non-responders:

• 10 mg IV in 500 mL normal saline over 8 hours 1
• Can be repeated every 8 hours for up to 24 hours 1

Clonazepam

• May be considered for maintenance therapy after acute stabilization 9, 10
• Cross-tapering from lorazepam to clonazepam is challenging and may result in relapse 9

Adjunctive and Alternative Agents

Memantine (NMDA Antagonist)

For refractory catatonia or as adjunctive therapy, memantine shows promise 11, 12, 13, 4, 10:

• Starting dose: 5 mg once daily 12
• Titration schedule: Increase by 5 mg increments weekly 12
  • Week 1: 5 mg daily
  • Week 2: 10 mg daily (5 mg twice daily)
  • Week 3: 15 mg daily (5 mg + 10 mg split doses)
  • Week 4: 20 mg daily (10 mg twice daily)
• Target dose: 10-20 mg daily in divided doses 12, 13, 4
• Can produce rapid response (within days) in some cases 13
• Well-tolerated in adolescents and adults 10

Caution: Reduce dose to 5 mg twice daily maximum in severe renal impairment (CrCl 5-29 mL/min) 12

Amantadine

For refractory cases, amantadine may be considered 11, 4:

• Adult dose: 100 mg twice daily (200 mg total daily) 11
• Can start with 100 mg once daily in patients with serious medical illnesses, then increase after 1 week 11
• Maximum: 400 mg daily in divided doses for optimal response 11
• Onset of action typically within 48 hours 11

Dose adjustments needed for congestive heart failure, peripheral edema, orthostatic hypotension, or renal impairment 11

Treatment Algorithm

1. Immediate intervention: Lorazepam 1-2 mg IV/IM/PO
2. Assess response at 2-4 hours: If inadequate, repeat dose
3. Establish maintenance: 6-12 mg daily in divided doses (every 4-8 hours)
4. If partial response by 24-48 hours: Increase to 16-24 mg daily OR add memantine
5. If no response by 48-72 hours: Consider ECT (most effective for refractory cases) 3, 10, 5
6. For lorazepam unavailability: Use midazolam or diazepam as outlined above

Critical Pitfalls to Avoid

• Do not use inadequate doses: 2 mg lorazepam appears optimal for initial challenge; lower doses may miss response 2
• Do not abruptly discontinue benzodiazepines: Can cause relapse or loss of response, requiring higher doses 9
• Monitor for tolerance: Some patients require dose escalation over months; consider temporary discontinuation and reinitiation 9
• Do not delay ECT: If benzodiazepines fail within 48-72 hours, ECT should be initiated promptly 3, 10, 5
• Avoid respiratory depression: When combining benzodiazepines with other sedatives, use lower doses and monitor closely 14

Maintenance Therapy Considerations

• Some patients require indefinite benzodiazepine maintenance after failed taper attempts 9
• Chronic tolerance may develop, requiring dose increases in approximately 44% of long-term cases 9
• For maintenance, continue the effective acute dose or consider transition to longer-acting agents like clonazepam (though this carries relapse risk) 9, 10